Imagine a world where the devastating effects of Alzheimer’s could be reversed, where the brain’s decline isn’t an inevitable sentence but a condition we might one day overcome. This is the tantalizing promise of a molecule that’s been quietly gaining traction among celebrities and scientists alike. But here’s where it gets controversial: could a simple supplement, costing just 42p per pill, hold the key to not only slowing aging but also restoring cognitive function in those battling Alzheimer’s? Let’s dive in.
Nicotinamide adenine dinucleotide, or NAD+, is a naturally occurring molecule that’s been making waves in the wellness world. While it’s been a favorite among longevity enthusiasts for its role in energy production and cellular repair, it’s now capturing the attention of mainstream science—and celebrities like Jennifer Aniston and Kendall Jenner. Aniston has openly praised NAD+ IV drips, calling them ‘the future,’ while Jenner was famously filmed receiving one alongside Hailey Bieber, who boldly declared, ‘I’m never going to age.’
But is this just another Hollywood fad, or is there real science behind the hype? A groundbreaking study led by researchers at The Harrington Discovery Institute (HDI) in Ohio suggests the latter. In experiments on mice genetically engineered to develop Alzheimer’s, scientists found that boosting NAD+ levels not only prevented memory loss but also reversed cognitive decline in animals already showing symptoms. The results were so striking that Dr. Andrew A. Pieper, the study’s senior author, described them as ‘very exciting and encouraging.’
And this is the part most people miss: the study didn’t just show improvement—it demonstrated full recovery of cognitive function in mice with advanced Alzheimer’s. This raises a bold question: Could NAD+ be the key to unlocking a cure for a disease that affects over half a million people in the UK alone, with numbers projected to soar to 1.4 million by 2040?
Before you rush to stock up on NAD+ supplements, there’s a crucial caveat. While the study’s findings are promising, they were conducted on mice, and translating these results to humans isn’t straightforward. Here’s the controversial bit: previous research has shown that NAD+ supplements can raise levels to dangerously high concentrations, potentially promoting cancer. In the HDI study, mice were closely monitored to ensure NAD+ levels stayed within a safe range—something that’s far more challenging to achieve outside a controlled clinical setting.
So, where does this leave us? The study, published in Cell Press Medicine, offers a glimmer of hope for Alzheimer’s patients and their families. As Dr. Pieper puts it, ‘The key takeaway is a message of hope—the effects of Alzheimer’s disease may not be inevitably permanent.’ But the road to a human treatment is long and fraught with challenges. Clinical trials are needed to confirm whether NAD+ can safely and effectively reverse Alzheimer’s in people, not just mice.
In the meantime, the supplement is readily available, with prices starting at £24.95 for a bottle. But should you try it? That’s a decision best made in consultation with your doctor. What do you think? Is NAD+ the next big breakthrough in Alzheimer’s research, or is it just another overhyped supplement? Let us know in the comments below—we’d love to hear your thoughts!
